Coronavirus vaccine: What is transverse myelitis, the medical condition that paused Oxford trials
The initial symptoms of Transverse myelitis include pain in the lower back or sharp, shooting sensations that radiate down the arms, legs, or around the torso
- Sep 9, 2020,
- Updated Sep 10, 2020 10:11 AM IST
British-Swedish pharma firm AstraZeneca said on Tuesday that it had halted late-stage clinical trials of its coronavirus vaccine after a study participant developed an adverse reaction.
The inoculation called AZD1222, which is undergoing phase 2/3 trials, is being tested on thousands of people around the world, including over 17,000 volunteers in the UK.
Although the reaction was a routine hiccup that usually occurs during clinical trials, the company did not divulge any further details on the nature of the illness in the study participant, or when the (last stage) trial is expected to resume.
British-Swedish pharma firm AstraZeneca said on Tuesday that it had halted late-stage clinical trials of its coronavirus vaccine after a study participant developed an adverse reaction.
The inoculation called AZD1222, which is undergoing phase 2/3 trials, is being tested on thousands of people around the world, including over 17,000 volunteers in the UK.
Although the reaction was a routine hiccup that usually occurs during clinical trials, the company did not divulge any further details on the nature of the illness in the study participant, or when the (last stage) trial is expected to resume.